What is Ginkgo Bioworks's trading assets?

Ginkgo Bioworks (DNA) reported trading assets of $179.22M in Q1 2026.

What does trading assets mean?

Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.

Ginkgo Bioworks DNA Trading assets

Trading assets at other companies

AzentaAZTA

$146.48M—

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's trading assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's trading assets?: Ginkgo Bioworks (DNA) reported trading assets of $179.22M in Q1 2026.
What does trading assets mean?: Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.